CTRI/2020/06/026002尚未招募2 期
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush-64) add-on therapy for patients with COVID-19 infection (Stage I)-An Open labelled, Parallel Group, Randomized controlled clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of 18-60 yrs of age, clinically diagnosed with corona virus disease 2019 by RTPCR test coming under stage I- mild (Early infection)
- •2.Participants who can take medicines orally.
- •3.Patients willing to provide signed informed consent.
排除标准
- •1.Pregnant, Lactating women, patients with CKD (Chronic Kidney Disease).
- •2.Not willing to participate in the study.
研究者
相似试验
尚未招募
不适用
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illnessCTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
已完成
3 期
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)CTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
已完成
2 期
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptomsCTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
尚未招募
不适用
Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiotaCTRI/2020/10/028746AMRIT GODBOLE
已完成
2 期
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80